How I treat hepatitis C virus infection in patients with hematologic malignancies

Efficacy of Sofosbuvir-Daclatasvir in Treatment of Chronic Hepatitis C Virus Infection

Lymphoid Malignancies and Direct-Acting Antivirals: Review Article

Clinical Impact of Hepatitis C Virus in Patients with B-Cell Non-Hodgkin Lymphoma

EFFICACY OF SOFOSBUVIR, DACLAVIR AND RIBAVIRIN IN TREATMENT OF HCV INFECTION WITH DIFFERENT STAGES OF LIVER DISEASE

Hematological Effects of Antiviral Drugs for Hepatitis C Virus

Hepatitis C Virus Load Kinetics and Clinical Outcome in Patients with Hematological Malignancies: Comparative Study of Autologous Bone Marrow Transplantation and Intensive Chemoth

Efficacy and Adverse Effects of Sofosbuvir-Based Therapies (Double and Triple Regimens) in Chronic HCV Patients

Pattern of Response to Sofosbuvir and Daclatasvir +/- Ribavirin Regimen in Chronic Hepatitis C Patients

Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis